BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10749665)

  • 1. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.
    Gómez del Pulgar T; Velasco G; Guzmán M
    Biochem J; 2000 Apr; 347(Pt 2):369-73. PubMed ID: 10749665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.
    Rueda D; Galve-Roperh I; Haro A; Guzmán M
    Mol Pharmacol; 2000 Oct; 58(4):814-20. PubMed ID: 10999952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.
    Sánchez C; Rueda D; Ségui B; Galve-Roperh I; Levade T; Guzmán M
    Mol Pharmacol; 2001 May; 59(5):955-9. PubMed ID: 11306675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor.
    Galve-Roperh I; Rueda D; Gómez del Pulgar T; Velasco G; Guzmán M
    Mol Pharmacol; 2002 Dec; 62(6):1385-92. PubMed ID: 12435806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
    Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
    J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.
    Wang L; Hayashi H; Kishi K; Huang L; Hagi A; Tamaoka K; Hawkins PT; Ebina Y
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):543-55. PubMed ID: 10642513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells.
    Kobayashi Y; Arai S; Waku K; Sugiura T
    J Biochem; 2001 May; 129(5):665-9. PubMed ID: 11328586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.
    Sotsios Y; Whittaker GC; Westwick J; Ward SG
    J Immunol; 1999 Dec; 163(11):5954-63. PubMed ID: 10570282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.
    Germack R; Dickenson JM
    Br J Pharmacol; 2000 Jun; 130(4):867-74. PubMed ID: 10864894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 cannabinoid receptor-mediated cell migration.
    Song ZH; Zhong M
    J Pharmacol Exp Ther; 2000 Jul; 294(1):204-9. PubMed ID: 10871313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones.
    Perkinton MS; Ip JK; Wood GL; Crossthwaite AJ; Williams RJ
    J Neurochem; 2002 Jan; 80(2):239-54. PubMed ID: 11902114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid ligand-receptor signaling in the mouse uterus.
    Das SK; Paria BC; Chakraborty I; Dey SK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
    Bouaboula M; Perrachon S; Milligan L; Canat X; Rinaldi-Carmona M; Portier M; Barth F; Calandra B; Pecceu F; Lupker J; Maffrand JP; Le Fur G; Casellas P
    J Biol Chem; 1997 Aug; 272(35):22330-9. PubMed ID: 9268384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.
    Delcommenne M; Tan C; Gray V; Rue L; Woodgett J; Dedhar S
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11211-6. PubMed ID: 9736715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.
    Glass M; Northup JK
    Mol Pharmacol; 1999 Dec; 56(6):1362-9. PubMed ID: 10570066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.